RarePlex Panel Kits
Circulating Tumor Cell Assays for Research
The RarePlex Panel Kit product line includes immunofluorescence Panel Kits and Developer Kits for circulating tumor cell (CTC) characterization, including enumeration, and specific kits include additional biomarkers for in-depth phenotypic characterization.
RarePlex Panel Kits are highly validated circulating tumor cell assays designed to work with the AccuCyte® Sample Preparation System, automated slide staining systems, and CyteFinder® Instruments.
Developer Kits are single channel kits and enable you to keep up with the pace of discovery. In order to provide you with assay flexibility, Developer Kits were designed to allow the addition of 1-2 biomarkers of your choice to a Panel Kit.
RarePlex® CTC Assays: Design and Analytical Validation for Circluating Tumor Cells
Presented by Dr. Tad George, Sr. VP of Biology R&D
RarePlex Assays are sensitive, specific, and reproducible assays for CTC detection and biomarker expression. Gain insight into the principles RareCyte applies to its assay design and validation process in this 11 minute video.
Panel Kits – Enumeration | ARv7 | AR/ARv7 | SYP | ARv7/SYP | HER2/ER | PD-L1
Developer Kits – 405/488
Download Specification Sheets
Download Test Menu Catalog
RarePlex Panel Kits
RarePlex Panel Kits are designed to work the RareCyte platform for circulating tumor cell analysis and are rigorously validated for sensitivity, specificity, and precision.
Enumeration Panel Kits include markers for circulating tumor cell identification and are performed on a Ventana or Leica automated slide staining system. With a 3-channel Panel Kit, you have the flexibility to create custom assays by adding up to two biomarkers with Developer Kits.
For in-depth phenotypic characterization, RareCyte offers Panel Kits with additional biomarkers such as HER2/ER and ARv7. With the ARv7 Panel Kit, you can choose to add an additional biomarker of your choice with a Developer Kit.
To learn more about available Panel Kits from RareCyte, select your Panel Kit below.
Clinical breast cancer samples stained with the HER2/ER CTC Panel Kit. Scale bar represents 10μm
| 405 | 488 | 555 | 647 | 800 | ||
| Enumeration Panel Kit |
 |
|
 |
 |
 |
 |
| Nuclei | CK/EpCAM | CD45 | CK/EpCAM, CD45, Nuclei | |||
| ARv7 Panel Kit |
|
 |
 |
 |
 |
 |
| ARv7 | Nuclei | CK/EpCAM | CD45 | CK/EpCAM, CD45, Nuclei | ||
| PD-L1 Panel Kit |
|
 |
 |
 |
 |
 |
| PD-L1 | Nuclei | CK/EpCAM | CD45 | CK/EpCAM, CD45, Nuclei | ||
| HER2/ER Panel Kit |
 |
 |
 |
 |
 |
 |
| HER2 | ER | Nuclei | CK/EpCAM | CD45 | CK/EpCAM, CD45, Nuclei | |
| *Open indicates channel may be used with a Developer Kit Scale bar represents 10μm. |
||||||
RarePlex Developer Kits for CTC Assay Development
RarePlex Developer Kits are designed to address cancer heterogeneity by enabling custom circulating tumor cell assay development for disease or assay-specific biomarker expression by circulating tumor cells. Developer Kits enable the addition of up to two biomarkers-of-interest to Panel Kits.
Keep your research current with the flexibility afforded by Developer technology.
AR and ARv7 CTC assay built with the ARv7 Panel Kit and a Developer Kit